Ad
related to: recall blood pressure medication 2022
Search results
Results From The WOW.Com Content Network
Another pharmaceutical company is recalling a blood pressure medication that could increase the risk of cancer if taken in large amounts. On Wednesday, Lupin Pharmaceuticals recalled four lots of ...
Pfizer recalled certain lots of its high blood pressure medication for containing high levels of nitrosamines, which can lead to increased cancer risk.
Nearly a week after Lupin Pharmaceuticals announced a voluntary recall of two types of blood pressure medications, the company continues to see its stock price slide (though the hit could have ...
Quinapril, sold under the brand name Accupril [2] by the Pfizer corporation, is a medication used to treat high blood pressure (hypertension), heart failure, and diabetic kidney disease. [1] [3] It is a first line treatment for high blood pressure. [3] It is taken by mouth. [1] [3] Common side effects include headaches, dizziness, feeling tired ...
It may be used alone or in addition to other blood pressure medication. [4] Up to six weeks may be required for the full effects to occur. [4] Common adverse effects include muscle cramps, stuffy nose, dizziness, cough, high blood potassium, and anemia. [4] Severe adverse effects may include angioedema, low blood pressure, and kidney problems. [4]
A drug recall removes a prescription or over-the-counter drug from the market. Drug recalls in the United States are made by the FDA or the creators of the drug when certain criteria are met. When a drug recall is made, the drug is removed from the market and potential legal action can be taken depending on the severity of the drug recall. [1]
A Duloxetine recall by the FDA has flagged more than 7,100 bottles of the Cymbalta generic drug due to a ... Increase in blood pressure. ... Some pharmacies offer on-site medicine drop-off boxes ...
2012 – 2018: From 2012 to 2018 massive amounts of generic versions of an entire class of angiotensin II inhibitor blood pressure medications (collectively called "sartans") were made with contaminated ingredients. Patients receiving these drugs were exposed to genotoxic and carcinogenic N-nitrosodimethylamine (NDMA) and N-nitrosodiethylamine ...